Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery.
Temozolomide, used for anaplastic gliomas and glioblastoma multiforme, is an oral drug that is stable under acidic, but labile under neutral and basic conditions. Although the bioavailability of temozolomide is approximately 100%, pathology or anatomical changes of the gastrointestinal tract may adversely affect absorption, and consequently therapeutic response. HPLC-UV was used to evaluate temozolomide plasma pharmacokinetics in a patient with unresponsive glioblastoma multiforme who had previously undergone gastric bypass as part of a weight-loss strategy. Temozolomide plasma pharmacokinetics were comparable to values reported for patients with normal gastrointestinal anatomy. These data imply that progression of disease in this patient was not due to inadequate temozolomide concentrations. Physicians need to become aware of the rapidly increasing population of patients who have had a gastric bypass and require oral therapy, of which our case is representative. The effect of gastric bypass on pharmacokinetics will need to be evaluated on a drug-by-drug basis.
Park
Deric M
DM
Department of Neurological Surgery, University of Pittsburgh School of Medicine, PA 15261, USA.
Shah
Dhvani D
DD
Egorin
Merrill J
MJ
Beumer
Jan H
JH
D000970:Antineoplastic Agents / Q000097:blood / Q000627:therapeutic use; D002872:Chromosome Deletion; D002899:Chromosomes, Human, Pair 9; D003131:Combined Modality Therapy; D003399:Craniotomy; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D015390:Gastric Bypass; D005909:Glioblastoma / Q000188:drug therapy* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery; D000077204:Temozolomide
D000970:Antineoplastic Agents; D003606:Dacarbazine; D000077204:Temozolomide